Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Madrigal Pharmaceuticals
Pharma
ExCellThera's novel blood cancer cell therapy gains CHMP nod
Among its positive recommendations, Europe’s CHMP has blessed ExCellThera’s Zemcelpro, a stem cell transplant treatment for adults with blood cancers.
Kevin Dunleavy
Jun 20, 2025 11:55am
Madrigal touts biomarker data in key MASH population
May 12, 2025 2:00pm
Madrigal's first-ever MASH drug beats sales projections again
May 2, 2025 11:00am
'No weakness' in Madrigal's Rezdiffra MASH launch, says CEO
Feb 27, 2025 11:19am
Recapping Fierce Pharma's top stories of the year
Dec 23, 2024 3:00am
Amid a new MASH market, ‘tremendous change’ is on the horizon
Nov 5, 2024 10:02am
